J. Goldman & Co »

Trevi Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $185k 138k 1.34
2023-09-30 $301k 138k 2.18
2023-06-30 $330k 138k 2.39
2023-03-31 $165k 89k 1.85
2022-12-31 $172k 89k 1.93
2022-09-30 $137k 89k 1.54
2022-06-30 $379k 135k 2.81